Waverley Pharma (TSXV:WAVE) Inventories, Finished Goods : C$0.00 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Inventories, Finished Goods?

Waverley Pharma's quarterly finished goods declined from Sep. 2023 (C$0.09 Mil) to Dec. 2023 (C$0.00 Mil) and declined from Dec. 2023 (C$0.00 Mil) to Mar. 2024 (C$0.00 Mil).

Waverley Pharma's annual finished goods declined from Dec. 2021 (C$0.33 Mil) to Dec. 2022 (C$0.06 Mil) and declined from Dec. 2022 (C$0.06 Mil) to Dec. 2023 (C$0.00 Mil).

Waverley Pharma Inventories, Finished Goods Historical Data

The historical data trend for Waverley Pharma's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Inventories, Finished Goods Chart

Waverley Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.09

0.27

0.33

0.06

Waverley Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															0.12	0.15	0.09	-	-

Waverley Pharma Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Waverley Pharma (TSXV:WAVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

5GZ:Germany

Address

1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.waverleypharma.com

Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.

Executives

Albert David Friesen

10% Security Holder, Director, Senior Officer